西藏药业：累计斥资1.78亿元回购1.24%股份

Group 1 - The company announced a share repurchase plan starting on December 18, 2025, with an expected buyback amount between 170 million to 200 million yuan for employee stock ownership plans or equity incentives [1] - The implementation period for the repurchase plan is set to end on December 17, 2026 [1] - As of the end of January 2026, the company has repurchased a total of 4.0001 million shares, accounting for 1.24% of the total share capital, with a total expenditure of 178 million yuan and a repurchase price range of 42.66 yuan to 45.98 yuan per share [1]